NCT05818956View on ClinicalTrials.gov

A Study of TAK-227 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 25, 2023

Primary Completion Date

June 19, 2023

Study Completion Date

June 26, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-227

TAK-227 capsules.

Trial Locations (1)

85283

Celerion, Inc., Tempe

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT05818956 - A Study of TAK-227 in Healthy Adults | Biotech Hunter | Biotech Hunter